PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,712 | -31.9% | 25,432 | -13.6% | 0.00% | – |
| Q2 2023 | $385,696 | -76.7% | 29,420 | -80.2% | 0.00% | – |
| Q1 2023 | $1,658,000 | +340351.7% | 148,218 | +156.4% | 0.00% | – |
| Q4 2022 | $487 | -99.9% | 57,814 | +76.5% | 0.00% | – |
| Q3 2022 | $545,000 | +16.7% | 32,763 | +3.2% | 0.00% | – |
| Q2 2022 | $467,000 | -29.8% | 31,737 | +18.4% | 0.00% | – |
| Q1 2022 | $665,000 | -59.8% | 26,810 | -48.0% | 0.00% | – |
| Q4 2021 | $1,655,000 | -71.1% | 51,604 | -67.6% | 0.00% | -100.0% |
| Q3 2021 | $5,728,000 | +960.7% | 159,193 | +1201.3% | 0.00% | – |
| Q2 2021 | $540,000 | -89.7% | 12,233 | -89.3% | 0.00% | -100.0% |
| Q1 2021 | $5,240,000 | +174.5% | 114,551 | +314.1% | 0.00% | – |
| Q4 2020 | $1,909,000 | – | 27,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $1,494,000 | 12.13% |
| Miura Global Management | 595,000 | $14,762,000 | 4.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,695,341 | $91,681,000 | 2.05% |
| Millrace Asset Group, Inc. | 78,859 | $1,956,000 | 1.42% |
| NEXT CENTURY GROWTH INVESTORS LLC | 436,034 | $10,818,000 | 1.08% |
| Novo Holdings A/S | 410,155 | $10,176,000 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 589,722 | $14,631,000 | 0.47% |
| Rock Springs Capital Management LP | 702,400 | $17,427,000 | 0.44% |
| RTW INVESTMENTS, LP | 798,255 | $19,805,000 | 0.41% |
| Regis Management CO LLC | 82,070 | $2,036,000 | 0.36% |